20Apr 2025
Study Shows Lower MACE and Mortality Risk for Black Prostate Cancer Patients on ADT

Study Shows Lower MACE and Mortality Risk for Black Prostate Cancer Patients on ADT

A real-world data study reveals that Black prostate cancer patients on androgen deprivation therapy (ADT) experience lower risks of major adverse cardiovascular events (MACE) and all-cause mortality compared to White patients, challenging previous findings that suggested racial disparities in outcomes.

  • #urology
  • #nephrology
  • #cardiology

Like

Save

Share